Skip to main content
Clinical Trials/JPRN-UMIN000024236
JPRN-UMIN000024236
Completed
未知

Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosis - Effect of Vonoprazan to gastroesophageal reflux disease with systemic sclerosis

Department of Gastroenterology Nagasaki University Hospital0 sites20 target enrollmentOctober 8, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Gastroenterology Nagasaki University Hospital
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2016
End Date
June 28, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastroenterology Nagasaki University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Liver and kidney dysfunction 2\. Allergy to many kind of drugs. 3\. Pregnant or who have a possibility to pregnancy, and under nursing patient. 4\. Participation to other study in 4 months. 5\. The study patient who decided to inadequacy by person in charge. 6\. Administration of atazanavir sulfate and rilpivirin hydrochloryde. 7\. Severe allergy or complication history of vonoprazan.

Outcomes

Primary Outcomes

Not specified

Similar Trials